Procter & Gamble Company (The) $PG Shares Sold by MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH

Key Points

• MEAG MUNICH ERGO reduced its holdings in Procter & Gamble by 11.4% during Q2, ending up with 17,394 shares valued at approximately $2.77 million.
• Procter & Gamble reported an EPS of $1.48 for the last quarter, exceeding expectations and marking a 1.7% year-over-year revenue increase.
• The company declared a quarterly dividend of $1.0568 per share, yielding 2.8% annually, with a payout ratio of 64.98%.

MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH lowered its position in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 11.4% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 17,394 shares of the company's stock after selling 2,231 shares during the period. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH's holdings in Procter & Gamble were worth $2,771,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of the company. Kingstone Capital Partners Texas LLC lifted its holdings in shares of Procter & Gamble by 655,209.0% in the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company's stock valued at $11,832,680,000 after purchasing an additional 76,017,350 shares in the last quarter. Nuveen LLC acquired a new position in shares of Procter & Gamble during the 1st quarter worth approximately $1,954,941,000. GAMMA Investing LLC lifted its stake in Procter & Gamble by 20,758.5% in the 1st quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company's stock valued at $1,355,087,000 after buying an additional 7,913,335 shares in the last quarter. Price T Rowe Associates Inc. MD grew its holdings in Procter & Gamble by 13.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock valued at $3,660,737,000 after buying an additional 2,466,308 shares during the last quarter. Finally, Invesco Ltd. increased its position in Procter & Gamble by 19.8% during the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company's stock worth $2,299,580,000 after buying an additional 2,228,151 shares in the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Procter & Gamble Trading Down 0.2%

Shares of PG stock opened at $152.18 on Friday. The firm's 50-day simple moving average is $156.05 and its 200-day simple moving average is $160.74. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. Procter & Gamble Company has a 1-year low of $149.91 and a 1-year high of $180.43. The firm has a market cap of $356.17 billion, a P/E ratio of 23.38, a PEG ratio of 4.02 and a beta of 0.36.

Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, topping the consensus estimate of $1.42 by $0.06. The firm had revenue of $20.89 billion during the quarter, compared to analyst estimates of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. Procter & Gamble's revenue for the quarter was up 1.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were issued a $1.0568 dividend. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date was Friday, July 18th. Procter & Gamble's dividend payout ratio (DPR) is 64.98%.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, CEO Gary A. Coombe sold 10,194 shares of the business's stock in a transaction that occurred on Thursday, August 21st. The shares were sold at an average price of $158.16, for a total transaction of $1,612,283.04. Following the completion of the sale, the chief executive officer directly owned 34,978 shares in the company, valued at $5,532,120.48. The trade was a 22.57% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Ma. Fatima Francisco sold 9,100 shares of the firm's stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $1,431,157.00. Following the completion of the transaction, the chief executive officer directly owned 27,295 shares in the company, valued at approximately $4,292,684.65. This represents a 25.00% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 120,181 shares of company stock worth $18,918,012. Company insiders own 0.20% of the company's stock.

Analysts Set New Price Targets

Several brokerages have recently issued reports on PG. UBS Group set a $180.00 price objective on Procter & Gamble and gave the company a "buy" rating in a research report on Wednesday, July 30th. BNP Paribas restated an "outperform" rating and issued a $177.00 target price on shares of Procter & Gamble in a report on Friday, August 15th. Berenberg Bank lifted their price target on shares of Procter & Gamble from $152.00 to $154.00 and gave the stock a "hold" rating in a report on Wednesday, September 17th. Wells Fargo & Company cut their price objective on shares of Procter & Gamble from $173.00 to $170.00 and set an "overweight" rating for the company in a research report on Thursday. Finally, Evercore ISI restated an "in-line" rating and set a $170.00 target price (down previously from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and eight have issued a Hold rating to the company. According to MarketBeat.com, Procter & Gamble currently has a consensus rating of "Moderate Buy" and an average target price of $173.78.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.